{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:56:18Z","timestamp":1787507778919,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2\/171\/Neuro\/2021-NCD-I"],"award-info":[{"award-number":["3\/1\/2\/171\/Neuro\/2021-NCD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.taap.2024.117172","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:38:05Z","timestamp":1732588685000},"page":"117172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2\/ARE pathway in Parkinson's disease"],"prefix":"10.1016","volume":"494","author":[{"given":"Amritha","family":"Chakkittukandiyil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Vasudevan","family":"Sajini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emdormi","family":"Rymbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Sugumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinu","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadivelan","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divakar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2024.117172_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-024-10965-y","article-title":"Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease","author":"Arumugam","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.taap.2024.117172_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.taap.2024.117172_bb0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2024.117172_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bpobgyn.2010.10.016","article-title":"Oxidative stress","volume":"25","author":"Burton","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"105325","key":"10.1016\/j.taap.2024.117172_bb0025","article-title":"The principal molecular mechanisms behind the activation of Keap1\/Nrf2\/ARE pathway leading to neuroprotective action in Parkinson's disease","volume":"156","author":"Chakkittukandiyil","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.taap.2024.117172_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in Parkinson's disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.taap.2024.117172_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098896","article-title":"Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO","volume":"9","author":"Cleasby","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2024.117172_bb0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/biom11040589","article-title":"Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions","volume":"11","author":"Consoli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.taap.2024.117172_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson's disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2024.117172_bb0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2024.117172_bb0055","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200105","article-title":"KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease","volume":"10","author":"Dayalan Naidu","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.taap.2024.117172_bb0060","first-page":"1803","article-title":"The Keap1\/Nrf2-ARE pathway as a pharmacological target for Chalcones","volume":"23","author":"de Freitas Silva","year":"2018","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.taap.2024.117172_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118691","article-title":"Ethnopharmacological validation of Karkataka Taila-an edible crab Rasayana in rotenone-induced in vitro and in vivo models of Parkinson's disease","volume":"335","author":"Deepika","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2024.117172_bb0070","series-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","author":"Dunham","year":"1957"},{"key":"10.1016\/j.taap.2024.117172_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/BJ20090471","article-title":"Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1","volume":"422","author":"Eggler","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2024.117172_bb0080","article-title":"Mechanisms of abemaciclib, a CDK4\/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro","volume":"15","author":"Eskiler","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.taap.2024.117172_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vascn.2018.03.007","article-title":"Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2\u2032, 7\u2032\u2013dichlorofluorescin diacetate (DCFDA) assay","volume":"94","author":"Figueroa","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.taap.2024.117172_bb0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MCB.25.1.162-171.2005","article-title":"BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase","volume":"25","author":"Furukawa","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2024.117172_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/026119290503301s07","article-title":"3.1. Acute toxicity","volume":"33","author":"Gribaldo","year":"2005","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.taap.2024.117172_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/680816","article-title":"Inhibition of nuclear Nox4 activity by Plumbagin: effect on proliferative capacity in human amniotic stem cells","volume":"2013","author":"Guida","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.taap.2024.117172_bb0105","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.18632\/aging.102394","article-title":"Neuroprotective effects of protocatechuic aldehyde through PLK2\/p-GSK3\u03b2\/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease","volume":"11","author":"Guo","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.taap.2024.117172_bb0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/10286020.2017.1339349","article-title":"Neuroprotective effect of \u03b1-mangostin on mitochondrial dysfunction and \u03b1-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells","volume":"19","author":"Hao","year":"2017","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.taap.2024.117172_bb0115","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2024.117172_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277477","article-title":"Rotenone causes mitochondrial dysfunction and prevents maturation in porcine oocytes","volume":"17","author":"Heo","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2024.117172_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2478\/s11535-009-0001-9","article-title":"Kainic acid lesion-induced spatial memory deficits of rats","volume":"4","author":"Hritcu","year":"2009","journal-title":"Open Life Sci."},{"key":"10.1016\/j.taap.2024.117172_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-16-12","article-title":"Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells","volume":"16","author":"Hsieh","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.taap.2024.117172_bb0135","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/jnr.21021","article-title":"D-\u03b2-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease","volume":"84","author":"Imamura","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.taap.2024.117172_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.taap.2024.117172_bb0145","doi-asserted-by":"crossref","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","article-title":"p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription","volume":"285","author":"Jain","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2024.117172_bb0150","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1021\/acs.jmedchem.6b00586","article-title":"Discovery and development of Kelch-like ECH-associated protein 1. Nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction inhibitors: achievements, challenges, and future directions","volume":"59","author":"Jiang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2024.117172_bb0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157488912803252023","article-title":"The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases","volume":"7","author":"Joshi","year":"2012","journal-title":"Recent Pat. CNS Drug Discov. Discontin."},{"key":"10.1016\/j.taap.2024.117172_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107989","article-title":"Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model","volume":"167","author":"Kim","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.117172_bb0165","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2024.117172_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.taap.2024.117172_bb0175","doi-asserted-by":"crossref","first-page":"1033003","DOI":"10.3389\/fphar.2022.1033003","article-title":"Michael acceptor molecules in natural products and their mechanism of action","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2024.117172_bb0180","series-title":"Annual Reports in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0065-7743(08)61137-9","article-title":"Chapter 27. Bioisosterism in Drug Design","author":"Lipinski","year":"1986"},{"key":"10.1016\/j.taap.2024.117172_bb0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","article-title":"The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: focus on organic pollutants","volume":"92","author":"Lopez-Suarez","year":"2022","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.taap.2024.117172_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2024.117172_bb0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of K eap1-N rf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.taap.2024.117172_bb0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fchem.2018.00426","article-title":"Microwave-assisted Knoevenagel-Doebner reaction: an efficient method for naturally occurring phenolic acids synthesis","volume":"6","author":"Mouterde","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.taap.2024.117172_bb0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.bbadis.2014.04.008","article-title":"The estrogen receptor \u03b2-PI3K\/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson's disease model. Biochim","volume":"1842","author":"Nakaso","year":"2014","journal-title":"Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.taap.2024.117172_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14715\/cmb\/2016.62.14.2","article-title":"Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1\/Nrf2 signaling pathway","volume":"62","author":"Pan","year":"2016","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.taap.2024.117172_bb0215","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1039\/c3ra41247d","article-title":"Chemo-enzymatic preparation of new bio-based bis-and trisphenols: new versatile building blocks for polymer chemistry","volume":"3","author":"Pion","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.taap.2024.117172_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.taap.2024.117172_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12731","article-title":"Neuroprotective effect of Ginsenoside re against neurotoxin-induced Parkinson's disease models via induction of Nrf2","volume":"25","author":"Qiao","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2024.117172_bb0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/tx700302s","article-title":"Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3","volume":"21","author":"Rachakonda","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2024.117172_bb0235","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.3390\/ijms21165712","article-title":"Cinnamic acid derivatives and their biological efficacy","volume":"21","author":"Ruwizhi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2024.117172_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122144","article-title":"The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models","volume":"333","author":"Rymbai","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2024.117172_bb0245","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2024.117172_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.taap.2024.117172_bb0255","first-page":"811","article-title":"Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress","volume":"6","author":"Scapagnini","year":"2004","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2024.117172_bb0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuint.2018.02.010","article-title":"Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats","volume":"116","author":"Sharma","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.taap.2024.117172_bb0265","first-page":"2333","article-title":"Azelaic acid attenuatesrotenone-induced behavioural alterations in parkinson's disease rat model","volume":"21","author":"Sharmaa","year":"2021","journal-title":"Plant Arch"},{"key":"10.1016\/j.taap.2024.117172_bb0270","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.taap.2024.117172_bb0275","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bbadis.2011.10.015","article-title":"Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders","volume":"1822","author":"Sultana","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2024.117172_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153576","article-title":"Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2\/Keap1\/SLC7A11 pathway in a microglia cell line","volume":"225","author":"Sun","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.taap.2024.117172_bb0285","article-title":"The Nrf2\/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Park. Dis."},{"key":"10.1016\/j.taap.2024.117172_bb0290","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s11064-024-04138-4","article-title":"Correction: Orientin modulates Nrf2-ARE, PI3K\/Akt, JNK-ERK1\/2, and TLR4\/NF-kB pathways to produce neuroprotective benefits in Parkinson's disease","volume":"49","author":"Vasudevan Sajini","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.taap.2024.117172_bb0295","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1021\/acschemneuro.8b00605","article-title":"Neuroprotective effect of Swertiamain on cerebral ischemia\/reperfusion injury by inducing the Nrf2 protective pathway","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2024.117172_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112385","article-title":"Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2\/keap1 pathway","volume":"199","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2024.117172_bb0305","article-title":"Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson's disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2024.117172_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01261-6","article-title":"Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents","volume":"11","author":"Yao","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.taap.2024.117172_bb0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","article-title":"The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: emphasizing the role of the calcium\/GSK3\u03b2 pathway","volume":"233","author":"Yuan","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2024.117172_bb0320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuint.2016.09.004","article-title":"Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells","volume":"106","author":"Zagoura","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.taap.2024.117172_bb0325","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects","article-title":"Pharmacological treatment of Parkinson's disease","author":"Zahoor","year":"2018"},{"key":"10.1016\/j.taap.2024.117172_bb0330","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2016.11.020","article-title":"Subcutaneous rotenone rat model of Parkinson's disease: dose exploration study","volume":"1655","author":"Zhang","year":"2017","journal-title":"Brain Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:53:05Z","timestamp":1733979185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24003715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":66,"alternative-id":["S0041008X24003715"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117172","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2\/ARE pathway in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117172"}}